Single-shot HIV vaccine candidate induces neutralizing antibodies for the first time

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in ...
Healio

TULIP-SC: Subcutaneous anifrolumab bests placebo in multiple lupus outcomes at 52 weeks

Subcutaneous anifrolumab is superior to placebo in multiple systemic lupus erythematosus disease activity measures at 52 ...

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that ...
News-Medical.Net on MSN

Single-dose HIV vaccine candidate induces neutralizing antibodies

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in ...
CURE

FDA Approves Larger Nelarabine Vial for Some Leukemias and Lymphomas

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
Endocrinology Advisor

Afrezza Label Update Clarifies Transition From SC to Inhaled Mealtime Insulin

New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.